Is the following accurate?

1. Colorectal Cancer (CRC)
Trial Phase: Phase 2

Status: Enrolling as of early 2025

Notes: FDA has cleared the trial; started enrolling patients in January
2025.

2. Metastatic Triple-Negative Breast Cancer (mTNBC)
Trial Phase: Phase 1b/2 (previously completed)

Status: Trial completed; survival data is being analyzed and prepared for
presentation

Notes: Long-term survivors observed; data will be presented at ESMO
Breast Cancer 2025.

3. Liver Fibrosis
Trial Phase: Preclinical

Status: Ongoing in animal studies

Notes: Significant reversal of fibrosis observed; human trials not yet
started.

4. HIV / COVID-19
Trial Phase: Various (previous trials)

Status: On hold or inactive

Notes: No current activity; focus has shifted to oncology and liver fibrosis.